Core Viewpoint - Hengtong Holdings has shown significant stock performance with a year-to-date increase of 72.55%, despite a recent decline of 4.76% over the past five trading days [1] Financial Performance - For the first half of 2025, Hengtong Holdings achieved a revenue of 818 million yuan, representing a year-on-year growth of 45.80%, and a net profit attributable to shareholders of 127 million yuan, up 8.91% year-on-year [2] Stock Market Activity - As of October 21, Hengtong Holdings' stock price was 4.40 yuan per share, with a market capitalization of 13.087 billion yuan. The stock experienced a trading volume of 63.78 million yuan and a turnover rate of 0.49% [1] - The company has seen a net inflow of main funds amounting to 5.1236 million yuan, with significant buying activity from large orders [1] Shareholder Information - As of June 30, the number of shareholders for Hengtong Holdings was 34,200, an increase of 0.64% from the previous period, with an average of 86,876 circulating shares per shareholder, a decrease of 3.39% [2] Business Overview - Hengtong Holdings, established on May 11, 1999, and listed on November 16, 1999, is primarily engaged in the production and sales of biopesticides, veterinary drugs, feed additives, and related services. The main revenue sources are electrolytic copper foil (67.62%), electricity and steam (16.17%), and veterinary drugs (16.14%) [1][2] Dividend Information - Since its A-share listing, Hengtong Holdings has distributed a total of 709 million yuan in dividends, with no dividends paid in the last three years [3]

Core Viewpoint - The company, Hengtong Optic-Electric Co., Ltd., expressed its commitment to enhancing core competitiveness and profitability while actively rewarding shareholders and sharing the results of corporate development [2] Summary by Categories - **Company Strategy** - The company aims to continuously improve its core competitiveness and profitability [2] - There is a focus on actively returning value to shareholders [2] - **Shareholder Engagement** - Hengtong plans to share the achievements of its development with shareholders [2]

Core Viewpoint - Hengtong Holdings has experienced a significant stock price increase of 83.14% year-to-date, despite a recent decline of 2.10% in its stock price on October 16, 2023, indicating volatility in the market [1]. Group 1: Stock Performance - As of October 16, 2023, Hengtong's stock price is reported at 4.67 CNY per share, with a total market capitalization of 13.89 billion CNY [1]. - The stock has seen a trading volume of 1.68 billion CNY, with a turnover rate of 1.20% [1]. - Year-to-date, the stock has increased by 83.14%, with a 1.06% decline over the last five trading days, a 29.36% increase over the last 20 days, and a 58.84% increase over the last 60 days [1]. Group 2: Financial Metrics - For the first half of 2025, Hengtong achieved a revenue of 818 million CNY, representing a year-on-year growth of 45.80%, and a net profit attributable to shareholders of 127 million CNY, reflecting an 8.91% increase [2]. - The company's main revenue sources include electrolytic copper foil (67.62%), electricity and steam (16.17%), and veterinary medicine (16.14%) [2]. Group 3: Shareholder Information - As of June 30, 2023, Hengtong had 34,200 shareholders, an increase of 0.64% from the previous period, with an average of 86,876 circulating shares per shareholder, a decrease of 3.39% [2]. - The company has cumulatively distributed 709 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3].

Core Viewpoint - Hengtong Co., Ltd. (600226) is actively engaged in the research, production, and sales of its main business areas, which include electrolytic copper foil, veterinary pharmaceuticals, feed additives, and cogeneration [1] Business Overview - The company has made investments and strategic arrangements around its main business, indicating a proactive approach to growth and diversification [1] - Hengtong and its wholly-owned subsidiaries have invested in and hold stakes in several companies, including Qingdao Yibang Bioengineering Co., Ltd. (17.45% stake), Hebei Shengxue Dacheng Pharmaceutical Co., Ltd. (49% stake), and Zhejiang Ikobike Animal Health Products Co., Ltd. (49% stake) [1]

Core Points - The company has approved the allocation of reserved shares for the 2024 employee stock ownership plan, allowing eligible participants to subscribe to a total of 6.21 million shares [5][6][14] Group 1: Employee Stock Ownership Plan - The 2024 employee stock ownership plan has been approved by the board and relevant committees, with a total of 6 million shares reserved for this plan [5][6] - The company has recovered 210,000 shares from employees who have left, bringing the total available for allocation to 6.21 million shares [5][6] - The subscription price for the reserved shares is set at 1.34 yuan per share, consistent with the initial subscription price [6][14] Group 2: Decision-Making Process - The decision-making process for the employee stock ownership plan has followed legal and regulatory requirements, ensuring no harm to the company's or shareholders' interests [7] - The board's compensation and assessment committee has confirmed that the allocation of reserved shares complies with the company's regulations and relevant laws [7][14] Group 3: Governance Changes - The company has decided to eliminate the supervisory board and the position of employee representative supervisor, in line with the revised Company Law [8][9] - The board has elected a new representative to execute company affairs, ensuring compliance with legal requirements [10][11]

Group 1 - The company, Hengtong Optic-Electric Co., Ltd., announced the removal of the supervisory board and supervisors according to the revised articles of association [2] - As of September 16, 2025, the company will terminate the position of employee representative supervisor held by Mr. Wang Bo, following a resolution from the employee representative assembly [2]

Core Viewpoint - Hengtong Optic-Electric Co., Ltd. announced the approval of its 2024 employee stock ownership plan, allowing the allocation of a total of 6.21 million shares to eligible participants [1] Group 1 - The company will allocate a total of 6.21 million shares from the 2024 employee stock ownership plan and shares recovered from departing employees [1] - The allocation will be made to no more than three eligible participants [1] - The decision was made during the 23rd meeting of the 9th Board of Directors held on September 16, 2025 [1]

Core Viewpoint - The company, Hengtong Holdings, emphasizes its focus on high-end copper foil products and its advancements in production capabilities, particularly in the electronic circuit and lithium battery sectors [1]. Group 1: Product Development - Hengtong Copper Foil has developed high-value-added products such as reverse copper foil (RTF), low-profile copper foil (LP), and high-temperature extension copper foil (HTE), which have already achieved mass production [1]. - The company is accelerating the development of ultra-low-profile copper foil HVLPⅢ, RTF-Ⅲ, and carrier copper foil [1]. Group 2: Production Capabilities - In the lithium battery copper foil segment, Hengtong Copper Foil has the capability to supply copper foil ranging from 4.5μm to 8μm in full batches and has mastered the production technology for 3.5μm copper foil [1].

浙江亨通控股股份有限公司 关于取消职工代表监事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 为贯彻落实新修订的《公司法》，按照中国证券监督管理委员会新修订颁布的《上 市公司章程指引》等规定，浙江亨通控股股份有限公司（以下简称"公司"）于 2025 年 8 月 22 日召开第九届董事会第二十二次会议、第九届监事会第十二次会议，于 2025 年 9 月 16 日召开 2025 年第二次临时股东大会，审议通过了《关于修订<公司章程>的 议案》。 根据修订后的《公司章程》，公司不再设置监事会、监事。2025 年 9 月 16 日， 公司董事会收到公司职工代表大会之会议决议，同意自 2025 年 9 月 16 日起免去王波 先生的职工代表监事职务。 王波先生担任职工代表监事的原定任期到期日为 2026 年 7 月 2 日。截至本公告 披露日，王波先生不存在应当履行而未履行的承诺事项，后续仍在公司担任其他职务。 公司对王波先生在任职期间为公司发展做出的贡献表示衷心的感谢！ 证券代码：600226 证券简称：亨通股份 公告编号：2 ...

Group 1 - The core point of the article is that Hengtong Optic-electric Co., Ltd. held its 23rd meeting of the 9th Board of Directors on September 16, 2025, to discuss various proposals, including the election of directors to represent the company in its operations [1] - For the fiscal year 2024, Hengtong's revenue composition is reported as 97.37% from industrial manufacturing and 2.63% from other businesses [1] - As of the report, Hengtong's market capitalization stands at 12.2 billion yuan [1]